Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dyslipidemia

Free Subscription 22.12.2025 3 Atherosclerosis 2 Circ Genom Precis Med 1 Int J Cardiol 2 J Clin Endocrinol Metab 2 Metabolism 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Atherosclerosis

1. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
   Association between C-reactive protein and adverse events in secondary cardiovascular prevention: A systematic review and meta-analysis of prognostic factor studies.
   Atherosclerosis. 2026;412:120574.
   PubMed         Abstract available
   
   
2. NOORDAM R, Wang W, Nagarajan P, Wang H, et al
   Genome-wide gene-sleep interaction study identifies novel lipid loci in 732,564 participants.
   Atherosclerosis. 2026;412:120603.
   PubMed         Abstract available
   
   
3. JOHN MANCINI GB, Ryomoto A, Ruel I, Iatan I, et al
   Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.
   Atherosclerosis. 2025;412:120590.
   PubMed         Abstract available
   
   

   
   Circ Genom Precis Med

4. SAMADDER NJ, Schroeder M, Voss MM, Shamoun F, et al
   Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System.
   Circ Genom Precis Med. 2025 Nov 12:e005174. doi: 10.1161/CIRCGEN.125.005174.
   PubMed         Abstract available
   
   
5. LEVY ME, Schiabor Barrett KM, Betts MN, Kann D, et al
   Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia.
   Circ Genom Precis Med. 2025 Nov 5:e005206. doi: 10.1161/CIRCGEN.125.005206.
   PubMed         Abstract available
   
   

   
   Int J Cardiol

6. BRUCATO F, Tognola C, Moreo A, Bellomare M, et al
   Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort study.
   Int J Cardiol. 2026;445:134046.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

7. SWARTZ AZ, Wood K, Farber-Eger E, Petty A, et al
   Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases.
   J Clin Endocrinol Metab. 2025;111:e49-e57.
   PubMed         Abstract available
   
   
8. ZHANG Y, Alzahrani M, Luu T, Fatunbi J, et al
   Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses.
   J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   Metabolism

9. ZHOU Y, Dai Y, Qin M, Li Y, et al
   FAM83A acts as an amplifier for lipogenic signaling to facilitate the pathogenesis of metabolic dysfunction-associated steatohepatitis.
   Metabolism. 2026;175:156462.
   PubMed         Abstract available
   
   
10. MARKAKIS K, Abadi LF, Kombe AK, Christodoulides M, et al
    HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?
    Metabolism. 2026;175:156432.
    PubMed         Abstract available
    
    

    
    PLoS One

11. HOJJAT CF, Teague AM, Tullier MA, Chadwick JQ, et al
    Effect of obesity and exercise training on circulating lipids in American Indian adolescents.
    PLoS One. 2025;20:e0338547.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.